Novartis Settles Kentucky Drug-Pricing Claims For $3M
Novartis Pharmaceuticals Corp. has struck a $2.75 million settlement with Kentucky over allegations that the drugmaker defrauded the state's Medicaid program by publishing false and inflated average wholesale prices for its...To view the full article, register now.
Already a subscriber? Click here to view full article